Stitch Fix, apparel retailers may benefit
Michelle Suter has worn mostly big and baggy clothing for years. The 63-year-old retiree who lives in a…
Tariffs and Iran war threaten India’s $100 billion garments export goal
Hello, this is Priyanka Salve, writing to you from Singapore. Welcome to the latest edition of “Inside India”…
UK faces rising bills as new tax year starts
The headquarters of HM Revenue and Customs near the Houses of Parliament in the Westminster district of London,…
Lilly seals up to $7.8 billion deal for Centessa in sleep disorder bet
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, U.S., Sept. 23, 2025.…
Eli Lilly reaches deal to bring AI-developed drugs to global market
A drone view shows the Eli Lilly logo on the company’s office in San Diego, California, Nov. 21,…
China Development Forum welcomes U.S. execs revamping market push
Apple CEO Tim Cook (L) stands with Siemens CEO Roland Busch prior to the opening ceremony of the…
Restaurants add protein, fiber for weight loss drug users
A mini burger, mini fries and mini beer, Clinton Hall’s “Teeny Weeny Mini Meal”, is pictured next to…
Eli Lilly launches program to boost employer coverage of obesity drugs
Eli Lilly on Thursday launched a new program designed to help more employers cover obesity drugs in the…
Why Novo Nordisk’s Ireland expansion is key to fighting off Eli Lilly
Novo Nordisk is investing 432 million euros ($506 million) in a facility in Ireland as it expands its…
Eli Lilly’s lead in the obesity race gets wider after win against Novo
In the lucrative obesity drug race, there is Eli Lilly — and then there’s everybody else. A pair…
These 4 charts show the scale of Novo Nordisk’s woes
Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
What’s next for Novo Nordisk’s obesity drug CagriSema
A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news…